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Complete Influenza Vaccination 
Trends for Children Six to 
Twenty-Three Months
Tammy A. Santibanez, PhD,a Lisa A. Grohskopf, MD,a Yusheng Zhai, MSPH,b Katherine E. Kahn, MPHb
abstractOBJECTIVE: Prevention of influenza among infants and young children is a public health 
priority because of their high risk for influenza-related complications. Depending on a 
child’s age and previous influenza vaccination history, they are recommended to receive 
either 1 dose or 2 doses of influenza vaccine to be considered fully vaccinated against 
influenza for the season. We compared estimates of full (complete) influenza vaccination 
coverage of children 6 to 23 months across 10 consecutive influenza seasons (2002–2012), 
by race/ethnicity, age group, and by number of doses required to be fully vaccinated given 
child’s vaccination history.
METHODS: National Immunization Survey data were used to estimate full influenza 
vaccination status among children 6 to 23 months on the basis of provider report. Estimates 
were computed by using Kaplan-Meier survival analysis methods.
RESULTS: Full influenza vaccination coverage among children 6 to 23 months increased 
from 4.8% in the 2002–2003 influenza season to 44.7% in the 2011–2012 season. In all 10 
influenza seasons studied, non-Hispanic black children and Hispanic children had lower 
full influenza vaccination coverage than non-Hispanic white children. For all 10 influenza 
seasons, full influenza vaccination coverage was higher among children requiring only 1 
dose compared with those requiring 2 doses.
CONCLUSIONS: Less than half of children 6 to 23 months in the United States, and an even 
a smaller percentage of Hispanic and non-Hispanic black children, are fully vaccinated 
against influenza. More implementation of evidence-based strategies that increase the 
percentage of children who are fully vaccinated is needed.
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WHAT’S KNOWN ON THIS SUBJECT: Infl uenza 
vaccination coverage with ≥1 dose based on parental 
report has been routinely assessed and reported 
since 2009 in the United States at http:// www. cdc. 
gov/ fl u/ fl uvaxview, but full infl uenza vaccination 
coverage (by parent or provider report) has not 
been assessed since then.
WHAT THIS STUDY ADDS: This study reports the 
percentage of children 6 to 23 months in the United 
States who were fully vaccinated against infl uenza 
during each of 10 consecutive infl uenza seasons 
(2002–2003 through 2011–2012) by race/ethnicity 
based on provider reported data.
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Prevention of influenza among 
infants and young children is a 
public health priority because 
of their high risk for influenza-
related complications. Before 2002, 
recommendations for influenza 
vaccination of children in the United 
States focused on those with health 
conditions that confer increased risk 
of severe illness from influenza.1 
Recommendations for the routine 
annual influenza vaccination of all 
children were first made in 2002, 
when the Advisory Committee on 
Immunization Practices (ACIP) voted 
to encourage providers to vaccinate 
all children aged 6 to 23 months, 
regardless of medical conditions.2 
In 2004, the ACIP explicitly 
recommended vaccination for all 
children 6 to 23 months.3 Later, in 
2006, these recommendations were 
expanded to include all children 6 to 
59 months and in 2008 to include all 
children 6 months to 18 years.4,5
Children 6 months through 8 years 
who are influenza vaccine–naive 
require 2 doses of vaccine for 
optimal immune response.6,7 The 
ACIP recommends that children 
6 months through 8 years receive 
either 1 dose or two doses spaced 
at least 4 weeks apart, depending 
on previous influenza vaccination 
history. The recommendations for 
determining the needed number of 
doses required to be considered fully 
vaccinated against influenza have 
changed over time (Table 1). For the 
2002–2003 through the 2006–2007 
seasons, 2 doses were recommended 
for children who had never 
received an influenza vaccination 
previously, otherwise 1 dose was 
recommended. In the 2007–2008 
season the recommendation for 2 
doses expanded to include those 
who should have received 2 doses 
in the previous season but received 
only 1 dose. The emergence of 
the pandemic 2009 H1N1 virus 
(H1N1pdm09) ahead of the 2009–
2010 influenza season led to the 
development of the monovalent 
pandemic vaccine, and 2 influenza 
vaccines were recommended during 
2009–2010: the trivalent seasonal 
influenza vaccination and the 
pandemic influenza A(H1N1)pdm09 
(pH1N1) monovalent vaccine.8 For 
the 2010–2011 season, given the 
relative antigenic novelty of the 
p(H1N1) virus, the recommended 
approach for determining the 
number of doses needed for young 
children was modified to consider 
both previous exposure to seasonal 
influenza vaccines and the pH1N1 
vaccine.9 During subsequent seasons 
up through the 2014–2015 season, 
the procedure for determining 
the number of doses needed 
continued to consider receipt of 
both seasonal influenza vaccine 
and the receipt of H1N1pdm09-
containing vaccine (Table 1), with 
some further variations depending 
on whether vaccine viruses had 
changed compared with the previous 
season.10–13
Influenza vaccination coverage 
with at least 1 dose based solely 
on parental report (ie, no provider 
verification) has been routinely 
assessed and reported since 2009, 
but full vaccination coverage has not 
been assessed since then.19 Obtaining 
full vaccination coverage measures 
based on parental report is more 
complicated because it requires the 
parent to remember and report the 
child’s lifetime history of influenza 
vaccination. Before the 2009–2010 
season, coverage with at least 1 
dose and full coverage based solely 
on provider-reported vaccination 
histories had been assessed among 
children 6 to 23 months, but these 
reports were discontinued due 
to lack of timeliness, that is, the 
estimates for 1 season were not 
available before the start of the next 
season due to the extended time 
needed to obtain provider-reported 
vaccination data. Furthermore, 
nationally representative provider-
reported data were not available for 
all of the age groups recommended to 
receive annual influenza vaccination 
as the recommendations expanded 
from children 6 to 23 months to all 
children 6 months and older.
This study focuses on children 6 to 
23 months because, among children, 
this age group has the highest risk 
of influenza-related complications, 
they were the first group of children 
for which a routine influenza 
recommendation was made, and this 
is an age group for which nationally 
representative provider-reported 
influenza vaccination histories are 
available from survey data. The 
aims of this study were to examine 
the percentage of children 6 to 23 
months who were fully vaccinated 
against influenza during each of 
10 consecutive influenza seasons, 
by race/ethnicity, age group, and 
number of doses required to be 
fully vaccinated given the child’s 
vaccination history. The estimates in 
this report can serve as a benchmark 
against which full vaccination 
coverage based on the more timely 
parental report can be compared 
once these measures are developed 
for all children 6 months through 8 
years.
METHODS
Survey Description
Data from the 2003 through 2012 
National Immunization Survey (NIS) 
were analyzed. The NIS is an ongoing, 
national, list-assisted random-
digit-dialed, land-line and cellular 
telephone survey of households with 
children 19 to 35 months.20 Cellular 
telephones were added to the NIS 
in 2011.21 The household telephone 
survey is followed by a mailed 
questionnaire, the Immunization 
History Questionnaire, to all of the 
immunization providers identified 
during the telephone survey and 
for which permission to contact 
them was granted by the parent. 
The influenza vaccination coverage 
estimates in this report are based 
only on the provider-reported 
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TABLE1  Full Infl uenza Vaccination Recommendations and Number of Doses Needed to be Fully Vaccinated, National Immunization Survey (NIS), Provider-
Report, United States, 2002–2003 Through 2011–2012 Infl uenza Seasons
Infl uenza 
Season
Recommendationsa Children Who 
Needed 2 Doses, % 
± 95% CIb
2002–2003 “Among previously unvaccinated children aged <9 years, two doses administered >1 months apart are recommended for 
satisfactory antibody responses.“2
99.2 ± 0.2
2003–2004 “Among previously unvaccinated children aged <9 years, two doses administered >1 month apart are recommended for 
satisfactory antibody responses.”14
96.5 ± 0.4
2004–2005 “Among previously unvaccinated children aged <9 years, 2 doses administered >1 month apart are recommended for 
satisfactory antibody responses. If possible, the second dose should be administered before December. If a child aged 
<9 years receiving vaccine for the fi rst time does not receive a second dose of vaccine within the same season, only 1 
dose of vaccine should be administered the following season. Two doses are not required at that time.”3
92.0 ± 0.6
2005–2006 “Among previously unvaccinated children aged <9 years, 2 doses administered >1 month apart are recommended for 
satisfactory antibody responses. If possible, the second dose should be administered before December. If a child aged 
<9 years receiving vaccine for the fi rst time does not receive a second dose of vaccine within the same season, only 1 
dose of vaccine should be administered the following season. Two doses are not required at that time.”15
81.5 ± 0.8
2006–2007 “Among previously unvaccinated children aged 6 months–<9 years, 2 doses of inactivated vaccine administered >1 
month apart are recommended for eliciting satisfactory antibody responses. If possible, the second dose should be 
administered before the onset of infl uenza season. If a child aged 6 months–<9 years receiving infl uenza vaccine for 
the fi rst time does not receive a second dose of vaccine within the same season, only 1 dose of vaccine should be 
administered the following season. Two doses are not required at that time.”16
81.0 ± 1.0
2007–2008 “ACIP recommends 2 vaccine doses for children aged 6 months–8 years who received an infl uenza vaccine (either TIV 
or LAIV) for the fi rst time in the previous season but who did not receive the recommended second dose of vaccine 
within the same season. ACIP recommendations are now harmonized with regard to this issue with those of AAP. This 
recommendation represents a change from the 2006 recommendations, in which children aged 6 months–8 years who 
received only 1 dose of vaccine in their fi rst year of vaccination were recommended to receive only a single dose in the 
following season. ACIP does not recommend that a child receive infl uenza vaccine for the fi rst time in the spring with 
the intent of providing a priming dose for the following season. Children recommended for vaccination who are in their 
third or more year of being vaccinated and who received only 1 dose in each of their fi rst 2 years of being vaccinated 
should continue receiving a single annual dose.”17
88.7 ± 0.6
2008–2009 “All children aged 6 months–8 years who have not received vaccination against infl uenza previously should receive 2 doses 
of vaccine the fi rst infl uenza season that they are vaccinated. The second dose should be administered 4 or more weeks 
after the initial dose. For example, children aged 6 months–8 years who were vaccinated for the fi rst time during the 
2007–08 infl uenza season but only received 1 dose during that season should receive 2 doses of the 2008–09 infl uenza 
vaccine. All other children aged 6 months–8 years who have previously received 1 or more doses of infl uenza vaccine at 
any time should receive 1 dose of the 2008–09 infl uenza vaccine. Children aged 6 months–8 years who only received a 
single vaccination during a season before 2007–08 should receive 1 dose of the 2008–09 infl uenza vaccine.”18
87.6 ± 0.8
2009–2010 “All children aged 6 months–8 years who have not received vaccination against infl uenza previously should receive 2 
doses of vaccine the fi rst infl uenza season that they are vaccinated. The second dose should be administered 4 or more 
weeks after the initial dose. When only 1 dose is administered to children aged 6 months–8 years during their fi rst year 
of vaccination, 2 doses should be administered in the following season. However, 2 doses should only be administered 
in the fi rst season of vaccination, or in the season that immediately follows if only 1 dose is administered in the fi rst 
season. For example, children aged 6 months–8 years who were vaccinated for the fi rst time with the 2008–09 infl uenza 
vaccine but received only 1 dose should receive 2 doses of the 2009–10 infl uenza vaccine. All other children aged 6 
months–8 years who have previously received 1 or more doses of infl uenza vaccine at any time should receive 1 dose of 
the 2009–10 infl uenza vaccine. Children aged 6 months–8 years who received only a single vaccination during a season 
before 2007–08 should receive 1 dose of the 2009–10 infl uenza vaccine.”5
84.4 ± 0.8
2010–2011 “All children aged 6 months–8 years who receive a seasonal infl uenza vaccine for the fi rst time should be administered 2 
doses. Children aged 6 months–8 years who received a seasonal vaccine for the fi rst time during 2009–2010 but who 
received only 1 dose should receive 2 doses, rather than 1, during 2010–2011. In addition, for the 2010–11 infl uenza 
season, children aged 6 months–8 years who did not receive at least 1 dose of an infl uenza A (H1N1) 2009 monovalent 
vaccine should receive 2 doses of a 2010–11 seasonal infl uenza vaccine, regardless of previous infl uenza vaccination 
history. Children aged 6 months–8 years for whom the previous 2009–10 seasonal or infl uenza A (H1N1) 2009 
monovalent vaccine history cannot be determined should receive 2 doses of a 2010–11 seasonal infl uenza vaccine.”9
90.3 ± 0.6
2011–2012 “Vaccination providers should note that, in previous seasons, children aged 6 months through 8 years who received only 
1 dose of infl uenza vaccine in their fi rst year of vaccination required 2 doses the following season. However, because 
the 2011–12 vaccine strains are unchanged from the 2010–11 season, children in this age group who received at least 
1 dose of the 2010–11 seasonal vaccine will require only 1 dose of the 2011–12 vaccine. Children in this age group who 
did not receive at least 1 dose of the 2010–11 seasonal infl uenza vaccine, or for whom it is not certain whether the 
2010–11 seasonal vaccine was received, should receive 2 doses of the 2011–12 seasonal infl uenza vaccine.”10
70.1 ± 1.2
CI, confi dence interval.
a Recommendations regarding which children required 2 doses versus 1 dose to be fully vaccinated against infl uenza, as published in the annual “Prevention and Control of Infl uenza: 
Recommendations of the Advisory Committee on Immunization Practices (ACIP),” published in Morbidity and Mortality Weekly Report.
b Aged 6 to 23 months.
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vaccinations. Providers reported the 
entire lifetime history of influenza 
vaccination on the Immunization 
History Questionnaire for every 
influenza season for which the child 
had received vaccination. Age was 
defined based on age on November 
1 of the influenza season under 
study, with this study being limited 
to children who were 6 to 23 months 
on November 1, realizing that some 
children would age out of this age 
range during the influenza season, 
but they and all of their vaccinations 
were included. For each influenza 
season, 2 full calendar years of NIS 
data files were combined for analysis 
of the influenza season beginning the 
previous calendar year. For example, 
to obtain estimates for the 2002–
2003 influenza season, the 2003 and 
2004 NIS data files were combined. 
This was necessary to obtain an equal 
distribution of children throughout 
the age range of 6 to 23 months. 
The race/ethnicity variable used in 
this study (Hispanic, non-Hispanic 
white only, non-Hispanic black only, 
non-Hispanic other or multiple race) 
is based on parent report of the 
child’s race and ethnicity; children of 
Hispanic ethnicity may be of any race. 
The household response rates for the 
NIS data included in this study, as 
defined by the Council of American 
Survey Research Organizations, 
ranged from 61.6% to 73.1% for 
the landline sample (2003–2012) 
and 25.2% to 30.6% for the cellular 
telephone sample (2011–2012).22 
The percentage for which adequate 
provider vaccination records were 
obtained among children with 
completed household interviews 
ranged from 63.6% to 72.3%.22 
Methodological details of the NIS 
have been previously published.20
Statistical Methods
The Kaplan-Meier survival analysis 
procedure was used to calculate 
the percentage of children fully 
vaccinated. The event variable was 
defined as the provider-reported 
month of the influenza vaccination 
dose that made the child fully 
vaccinated against influenza, either 
the first (or only) dose or the second 
dose. The number of doses needed 
was determined on the basis of the 
season-specific recommendations 
for number of doses required, as 
summarized in Table 1. The Kaplan-
Meier method was also used to 
calculate the percentage of children 
who received at least 1 dose of 
influenza vaccination (≥1 dose 
coverage), with the event variable 
defined as the provider-reported 
month of the child’s first influenza 
dose (regardless of their need for 1 
or 2 doses). Influenza vaccinations 
received during the entire influenza 
season from July through May were 
included in the coverage estimates. 
This method was used to estimate 
the percentage of children fully 
vaccinated against influenza overall 
and by age group, racial/ethnic 
group, and number of doses required 
to be fully vaccinated, and for the 
2011–2012 season only, by state.
Differences between influenza 
seasons within each group were 
tested by using t tests. Likewise, 
differences between groups within 
each influenza season were tested 
by using pairwise comparison t 
tests. Comparisons reported as 
being increases or decreases were 
statistically significant, whereas 
comparisons that were not 
statistically significant are reported 
as not being different. Reported 
percentages and corresponding 
95% confidence intervals were 
weighted, and reported sample 
sizes were unweighted. All analyses 
were weighted to population totals, 
unit nonresponse, and noncoverage 
of nontelephone households and 
to adjust for households having 
multiple telephone lines. Tests for 
linear trend were performed using 
a weighted linear regression on 
the season-specific estimates using 
season number as the independent 
variable and weights as the inverse 
of the estimated variance of the 
estimated vaccination coverage. 
Pairwise comparisons of estimates 
were conducted by using t tests 
assuming large degrees of freedom 
and used the value of 1.96 for 
the critical value. Analyses were 
conducted by using SAS release 9.3 
(SAS Inc, Cary, NC) and SUDAAN 
release 11.0.0 (Research Triangle 
Institute, Research Triangle Park, 
NC) statistical software to take into 
account the complex survey design. 
All statistical tests were 2-tailed 
with the significance level set at α 
< 0.05. Institutional review board 
approval for conducting the NIS was 
obtained through the National Center 
for Health Statistics Research Ethics 
Review Board and through the IRB of 
NORC at the University of Chicago.
RESULTS
Percentage of Children Requiring 2 
Doses
Among children 6 to 23 months, the 
percentage of children requiring 
2 doses to be considered fully 
vaccinated varied by influenza season 
as the dosage recommendations 
changed (Table 1). The percentage of 
children 6 to 23 months requiring 2 
doses to be fully vaccinated against 
influenza ranged from 70.1% for 
2011–2012 to 99.2% for the 2002–
2003 season.
Trends in Full Infl uenza Vaccination 
Coverage Overall
Full influenza vaccination coverage 
among children 6 to 23 months 
overall increased from the 
2002–2003 influenza season to the 
2011–2012 season (trend test P < 
.001; Table 2; Fig 1). The average 
annual increase was 4.2 percentage 
points based on the slope of the 
trend test. The estimates and annual 
changes from the previous season 
are denoted in Table 2. In only 2 of 
the 10 influenza seasons (the 2007–
2008 and the 2010–2011 seasons), 
there was no increase observed 
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in the percentage of children fully 
vaccinated compared with the 
previous season. Full influenza 
vaccination coverage by state for 
the 2011–2012 influenza season 
is presented in Table 3; coverage 
ranged from 23.6% in Mississippi to 
72.2% in Massachusetts.
Trends in Full Infl uenza Vaccination 
Coverage by Age Group
Within each age group studied, 
full influenza vaccination coverage 
increased from the 2002–2003 
influenza season to the 2011–2012 
season (trend test P < .001 each; 
Table 2). In 5 of the 10 influenza 
seasons studied (2003–2004, 
2004–2005, 2005–2006, 2006–2007, 
and 2011–2012), there were no 
differences between the age groups 
in full influenza vaccination coverage. 
In the remaining 5 seasons, children 
aged 6 to 11 months had higher full 
influenza vaccination coverage than 
children in the older age groups.
Trends in Full Infl uenza Vaccination 
Coverage by Race/Ethnicity
Within all 4 racial/ethnic groups 
studied, full influenza vaccination 
coverage increased from the 
2002–2003 influenza season to the 
2011–2012 season (trend test P 
< .001 each; Table 2). The change 
in vaccination coverage from one 
season to the next within each group 
is indicated in Table 2 including 
whether these changes were 
statistically significant.
In all 10 influenza seasons studied, 
non-Hispanic black children 
(hereafter referred to as black 
children) and Hispanic children 
had lower full influenza vaccination 
coverage than non-Hispanic white 
children (hereafter referred to as 
white children; Table 2; Fig 2). The 
gap in these racial/ethnic differences 
does not appear to decrease in 
magnitude over time. For example 
the percentage of black children fully 
vaccinated in the 2002–2003 season 
was 2.7%, whereas the percentage of 
white children fully vaccinated was 
6.1%, a difference of –3.4 percentage 
points; for the remaining seasons 
these black-white differences widen 
as follows: –7.3, –10.3, –11.9, –12.5, 
–13.7, –14.9, –14.2, –11.2, and –13.7 
percentage points. The Hispanic-
white differences by season were as 
follow: –3.4, –4.8, –8.2, –10.4, –8.6, 
–8.9, –9.6, –7.7, –5.3, and –8.8). In 
7 of the 10 seasons, black children 
also had lower full influenza 
vaccination coverage than Hispanic 
children.
Similar racial/ethnic differences 
were also seen among the estimates 
of coverage with at least 1 dose of 
influenza vaccination (Table 2). 
In all 10 influenza seasons, black 
children had lower ≥1 dose influenza 
vaccination coverage than white 
children. In 8 of the 10 seasons 
Hispanic children had lower coverage 
than white children, whereas in the 
2009–2010 and 2010–2011 seasons 
they had similar coverage.
Full Infl uenza Vaccination Coverage 
by Number of Doses Required
Among children who required 1 
dose to be fully vaccinated and 
among those who required 2 doses, 
full influenza vaccination coverage 
increased from the 2002–2003 
influenza season to the 2011–2012 
season (trend test P < .001 each; 
Table 2). The change in vaccination 
coverage from one season to the next 
within each group and whether these 
changes were statistically significant 
is indicated in Table 2. For all 10 
influenza seasons, full influenza 
vaccination coverage was higher 
among children requiring only 1 dose 
compared with those requiring 2 
doses (Table 2). For the 2011–2012 
season, among the subset of children 
6 to 23 months who required 
2 doses and received 1 dose, 63.7% 
received their required second 
dose, which can be viewed as the 
completion rate among those who 
began the series of 2 doses (not 
shown in tables).
DISCUSSION
This study found that full influenza 
vaccination coverage of children 6 to 
23 months increased from 4.8% in 
the 2002–2003 influenza season to 
44.7% in the 2011–2012 season. This 
is to be expected because previously 
published reports of coverage with at 
least 1 dose of influenza vaccination 
have shown increases during this 
time.19,23 Despite the increase, the 
majority of children 6 to 23 months 
in the United States were not fully 
vaccinated against influenza.
Previous reports of full influenza 
vaccination coverage of children 6 to 
23 months have been published using 
NIS provider-reported data, but these 
reports used a different estimation 
methodology (proportion estimate, 
subset of children 6 to 23 months 
during September–December and 
only included vaccinations through 
January).24–29 The estimates from 
previous reports compared with the 
estimates in this report are as follows 
for the 2002–2003 season through 
the 2009–2010 season: 4.4% versus 
4.8%, 8.4% versus 9.1%, 17.8% 
versus 19.2%, 20.6% versus 22.6%, 
21.3% versus 26.1%, 23.4% versus 
27.0%, 24.7% versus 31.4%, 30.1% 
versus 34.4%, respectively.24–29 
Note that the previous reports 
slightly underestimated full 
influenza vaccination coverage 
as expected because they did not 
count any vaccinations past January; 
reanalyzing these data using the 
improved Kaplan-Meir method 
rather than the proportion estimate, 
the censored nature of the data 
could be taken into account and all 
vaccinations counted. These reports 
were discontinued due to lack of 
timeliness of NIS provider-reported 
influenza data (ie, the estimates 
were not available before the start 
of the next influenza season due to 
the survey time needed to obtain 
provider-reported vaccination 
histories) and due to a need for 
influenza vaccination estimates 
for all children 6 months to 17 
5
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years. To address this, the NIS-Flu 
was developed, which can provide 
estimates of parental report of 
influenza vaccination coverage for 
children 6 months to 17 years for 
an influenza season before the start 
of the following influenza season.19 
Parental report of at least 1 dose 
of influenza vaccination has been 
reported based on the NIS-Flu data; 
however, parental report of full 
vaccination coverage has not yet been 
assessed. Full influenza vaccination 
coverage of children 6 to 23 months 
based on Immunization Information 
Systems sentinel site data compared 
with the national estimates from 
this report likewise showed slight 
differences: 35.9% versus 33.7%, 
respectively, for the 2010–2011 season 
and 44.3% versus 44.7%, respectively, 
for the 2011–2012 season.30
NIS estimates based on provider 
report are not as timely as estimates 
based on parental report due to the 
time needed to obtain vaccination 
information from all immunization 
providers. Additionally, for this study, 
2 full calendar years of interviews 
were used for each influenza season 
to have a more equal age distribution 
of children 6 months, 7 months, and 
up to 23 months; if only 1 calendar 
year was used, the sample would be 
weighted more heavily toward older 
children. Use of parental reported 
influenza vaccination allows for 
the timely production of influenza 
vaccination coverage estimates.19 
Obtaining parental report of full 
influenza vaccination, however, is 
more complicated because it requires 
the parental report of several past 
seasons of influenza vaccination, 
which may be more subject to recall 
bias. A thorough analysis of the 
validity of parent- versus provider-
reported child influenza vaccination is 
needed, including examining whether 
there are differences by race/
ethnicity. Initial indications, when 
examining the estimated number of 
people vaccinated, are that parent 
report overestimates influenza 
vaccination coverage.19 At least 1 
study did find differences in parental 
versus provider report by various 
sociodemographic characteristics, 
including race/ethnicity.31 The ≥1 
dose coverage estimates in this report, 
based on provider report, are lower 
than those based on the parental-
reported NIS-Flu estimates; a detailed 
validity study to quantify the extent of 
parental overreporting is warranted.19
7
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 FIGURE 1
Full infl uenza vaccination coverage among children aged 6 to 23 months by infl uenza season, NIS, 
provider report, United States, 2002–2003 through 2011–2012 infl uenza seasons. aEstimates obtained 
using Kaplan-Meier survival analysis methods and reported with 95% confi dence interval half-widths.
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Racial/ethnic differences in influenza 
vaccination coverage among 
adults have persisted over many 
influenza seasons.32 The finding that 
such differences also exist for full 
influenza vaccination coverage of 
young children is concerning. Broad 
use of evidence-based strategies 
that enhance access to vaccination 
services, increase demand for 
vaccinations, and use provider or 
system interventions are important 
components of efforts to increase 
vaccination coverage and reduce 
these differences.33 Furthermore, 
providers are encouraged to begin 
offering influenza vaccination soon 
after vaccine becomes available 
and to continue vaccination efforts 
throughout the influenza season. This 
is especially important for children 
who require 2 doses within the 
season to be fully protected.
This study is subject to at least 
3 limitations. First, the NIS is a 
telephone survey followed by a mail 
survey to immunization providers. 
Although statistical adjustments 
compensate for nonresponse and 
8
TABLE 3  Full Infl uenza Vaccination Coverage Among Children 6 to 23 Months by State, NIS, provider report, United States, 2011–2012 Infl uenza Season
Statea
Full Infl uenza 
Vaccination % ± 
95% CIb State
Full Infl uenza 
Vaccination % ± 
95% CIa State
Full Infl uenza 
Vaccination % ± 95% 
CIa
Massachusetts 72.2 ± 6.1 Colorado 50.6 ± 7.2 Florida 39.1 ± 7.1
Connecticut 71.1 ± 6.4 New York 50.4 ± 4.5 Alaska 38.9 ± 6.1
Rhode Island 65.3 ± 6.7 Arizona 49.9 ± 7.0 Kansas 38.7 ± 6.2
Vermont 64.9 ± 6.1 New Mexico 48.2 ± 6.5 Tennessee 38.6 ± 6.5
Delaware 64.5 ± 6.7 Illinois 48.0 ± 4.7 Utah 38.3 ± 6.4
Minnesota 63.6 ± 6.9 Washington 47.8 ± 7.2 Texas 36.7 ± 4.1
New Hampshire 62.7 ± 6.3 Michigan 47.7 ± 7.0 Iowa 34.9 ± 6.9
South Dakota 60.1 ± 6.8 Virginia 47.6 ± 8.6 Kentucky 34.5 ± 6.7
Hawaii 57.7 ± 6.6 Ohio 45.7 ± 6.6 Louisiana 33.8 ± 6.3
Wisconsin 57.5 ± 6.6 North Carolina 44.1 ± 6.7 West Virginia 33.5 ± 6.9
Pennsylvania 56.7 ± 5.3 Maryland 44.0 ± 7.0 Georgia 33.2 ± 7.0
Nebraska 56.6 ± 6.4 Oregon 43.7 ± 6.2 Alabama 32.9 ± 7.1
North Dakota 56.2 ± 6.5 California 43.0 ± 6.8 Wyoming 32.2 ± 6.7
Maine 55.4 ± 6.8 Montana 42.1 ± 6.8 Oklahoma 31.8 ± 6.3
New Jersey 55.2 ± 6.3 Indiana 42.0 ± 6.7 South Carolina 31.6 ± 6.3
District of Columbia 54.3 ± 7.1 Idaho 41.6 ± 7.2 Arkansas 26.6 ± 6.3
Missouri 51.6 ± 7.4 Nevada 40.8 ± 6.2 Mississippi 23.6 ± 6.3
CI, confi dence interval half-width.
a Ordered from highest to lowest full infl uenza vaccination coverage.
b Estimates obtained using Kaplan-Meier survival analysis methods.
 FIGURE 2
Full infl uenza vaccination coverage among children aged 6 to 23 months by infl uenza season and 
racial/ethnic group, NIS, provider report, United States, 2002–2003 through 2012–2013 infl uenza 
seasons. aEstimates obtained using Kaplan-Meier survival analysis methods and reported with 
confi dence interval half-widths. Estimates for the 2009–2010 season include only the seasonal 
infl uenza vaccine and exclude the 2009 H1N1 vaccine. bStatistically signifi cant (P < .05) differences 
between groups as well as the direction of the differences are as follows: 2002–2003: H < W; H < O; B < 
W; B < O; 2003–2004: H < W; H < O; B < H; B < W; B < O. 2004–2005: H < W; B < W; O < W; B < O; 2005–2006: 
H < W; H < O; B < W; B < O; O < W; 2006–2007: H<W; B < H; H < O; B < W; B < O; 2007–2008: H < W; B < 
H; H < O; B < W; B < O; 2008–2009: H < W; B < H; H < O; B < W; B < O; 2009–2010: H < W; B < H; H < O; 
B<W; B < O; 2011–2012: H < W; B < H; B < W; W < O; B < O; 2012–2013: H < W; B < H; H < O; B < W; B < O, 
where H, Hispanic; W, white only, non-Hispanic; B, black only, non-Hispanic; O, other or multiple race, 
non-Hispanic. All other pairwise comparisons not noted were not statistically signifi cant.
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households without telephones, 
bias might remain. Second, the 
NIS relies on provider reported 
vaccination histories; incomplete 
records and reporting might affect 
estimates. However, a previous 
study has shown that nearly all 
(97%) vaccinated children aged 6 to 
23 months received their influenza 
vaccination at a medical place (74% 
at a doctor’s office, 18% at a clinic or 
health center, and 5% at a hospital 
or emergency department).30 
Third, there was a change in the 
NIS sampling design from landline 
to dual frame (landline and cellular 
telephone), which should be taken 
into account when interpreting 
trends over time in NIS estimates.
CONCLUSIONS
Less than half of children aged 6 to 23 
months in the United States are fully 
vaccinated against influenza, and 
even a smaller percentage of Hispanic 
and non-Hispanic black children. 
Appropriate implementation of 
evidence-based strategies is needed 
to increase the percentage of children 
who are fully vaccinated. Prevention 
of influenza among infants and 
young children is a public health 
priority because of their high risk for 
influenza-related complications.
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